2Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis[J]. Lancet, 2007,369(9576) : 1876-1882.
3Gu W, Lu J, Yang G, et al. Plasma homocysteine thiolactone associated with risk of macrovasculopathy in Chinese patients with type 2 diabetes mellitus[J]. Adv Ther, 2008,25 (9) : 914- 924.
5de Luis DA, Fernandez N, Arranz ML, et al. Total homoeysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2 [J]. J Diabetes Complications,2005,19(1) :42-46.
6Fakhrzadeh H, Ghotbi S, Pourebrahim R, et al. Total plasma homocysteine,folate,and vitamin B12 status in healthy Iranian adults: the Tehran bomocysteine survey (2003-2004)/a crosssectional population based study[J]. BMC Public Health,2006, 6:29.
4Clarke R,Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease[J].N Engl J Med, 1991,324(17) : 1149-1155.
5Okada E, Oida K, Tada H, et al. Hyperhomoeysteinemia is a risk factor for coronary arterisosclerosis in Japanese patients with type 2 diabetes[J]. Diabetes Care, 1999,22 (3) : 484-490.
2Albert C M, Cook N R,Gaziano J M, et al. Effect of folic acidand B vitamins on risk of cardiovascular events and total mortali-ty among women at high risk for cardiovascular disease [J], JA-MA, 2008, 99 (17): 2027-2036.
